Feasibility, effectiveness, and experiences of music workshops for adolescents with anxiety and depression

Feasibility, effectiveness, and experiences of music workshops for adolescents with anxiety and depression, a Trial Within a Cohort Study as part of the research program: ‘Building resilience and resources to reduce depression and anxiety in young people from urban neighborhoods in Latin America (OLA)’

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN50583823

Enrollment

Registered

2022-04-21

Start date

2022-05-07

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescents with symptoms of depression and anxiety Mental and Behavioural Disorders

Interventions

This Trial Within a Cohort study (TWIC) is nested within a large cohort study that recruited participants with the condition of interest and follows them up over a period of time. Participants from th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All participants: 1. Enrolled in the OLA longitudinal cohort study 2. Aged 15-16 years when recruited to the OLA study 3. Symptoms of anxiety and/or depression at baseline and 6-month follow-up during the OLA study Intervention group only: 1. Capacity to provide assent 2. Informed consent provided by a parent/guardian

Exclusion criteria

Exclusion criteria: 1. Already regularly participate in a music band/orchestra, or have advanced music skills as determined during baseline assessment 2. Expressed no interest in participating in any arts activities during baseline assessment

Design outcomes

Primary

Measure	Time frame
Current primary outcome measure as of 14/02/2024: Effectiveness measured using self-rated depression/anxiety symptoms by the patient health questionnaire (PHQ-8) and the generalised anxiety disorder assessment (GAD-7) questionnaire at the beginning (baseline) and five (5) weeks Previous primary outcome measure as of 06/05/2022 to 14/02/2024: Effectiveness measured using the patient health questionnaire (PHQ-8) and the generalised anxiety disorder assessment (GAD-7) questionnaire at 12-months follow-up, adjusted for the 6-months follow-up scores, of intervention and control group, supplemented with pre-post intervention changes (baseline and 5 weeks) of self-rated depression/anxiety symptoms as measured by PHQ-8 and GAD-7 Previous primary outcome measure: Effectiveness measured using the patient health questionnaire (PHQ-8) and the generalised anxiety disorder assessment (GAD-7) questionnaire at baseline and 5 weeks	—

Measure

Time frame

Current primary outcome measure as of 14/02/2024: Effectiveness measured using self-rated depression/anxiety symptoms by the patient health questionnaire (PHQ-8) and the generalised anxiety disorder assessment (GAD-7) questionnaire at the beginning (baseline) and five (5) weeks Previous primary outcome measure as of 06/05/2022 to 14/02/2024: Effectiveness measured using the patient health questionnaire (PHQ-8) and the generalised anxiety disorder assessment (GAD-7) questionnaire at 12-months follow-up, adjusted for the 6-months follow-up scores, of intervention and control group, supplemented with pre-post intervention changes (baseline and 5 weeks) of self-rated depression/anxiety symptoms as measured by PHQ-8 and GAD-7 Previous primary outcome measure: Effectiveness measured using the patient health questionnaire (PHQ-8) and the generalised anxiety disorder assessment (GAD-7) questionnaire at baseline and 5 weeks

—

Secondary

Measure	Time frame
1. Feasibility measured using the acceptance of workshop participation and attendance of workshop sessions at 5 weeks 2. Experiences measured using open-ended exit questions at 5 weeks	—

Countries

Colombia

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 6, 2026